Google bets on European biotech drugs, backs new fund

June 14, 2017 By Ben Hirschler LONDON (Reuters) – Google is betting on the potential of European biotech companies to deliver life-changing drugs by investing alongside Swiss company Novartis in a new $300 million fund run by leading life sciences investment firm Medicxi. The move shows Google casting an increasingly wide net as it pumps cash into global medical research, seeding what it believes will become a core long-term healthcare business. Novartis and Verily, a unit of Google parent Alphabet, are cornerstone investors in the new fund, along with the…

Read More